What is it about?

Hypothyroidism is a recognized late adverse event following radiotherapy for head and neck cancer (HNC). In the JCOG1008 trial, we treated patients with high-risk HNC with postoperative chemoradiotherapy. We aimed to elucidate factors associated with hypothyroidism by analyzing the JCOG1008 data.

Featured Image

Perspectives

Recognizing and managing factors associated with hypothyroidism during radiotherapy is crucial to prevent a decline in the quality of life.

Naomi Kiyota
Kobe University Hospital

Read the Original

This page is a summary of: Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008, Oral Oncology, October 2024, Elsevier,
DOI: 10.1016/j.oraloncology.2024.106976.
You can read the full text:

Read

Contributors

The following have contributed to this page